The Medical Device Commercialisation Training Program (MDCTP) is delivered by Cicada Innovations in partnership with NSW Health, the program funder. The program is designed to accelerate commercialisation of medical technologies in NSW to bring lifesaving healthcare innovations to patients, hospitals and governments around the world.

The MDCTP offers an invaluable opportunity to NSW based medical device technologists to build knowledge, skills and network needed to successfully commercialise medical device technologies. 

There are three course streams available as part of the MDCTP to meet the needs of medical technologists at different stages of their journey that build upon each other:

  • CORE, our flagship course;

  • IP / Regulatory / Clinical Trial Workshops; and

  • Health Discovery

Applicants may apply from Startups, Universities, Research Institutes, the NSW Health System and Industry.


MDCTP CORE is designed for healthcare entrepreneurs from diverse backgrounds of medicine, engineering, science and business, and provides a tailored curriculum on how to transform their visionary concepts into viable businesses. 

Since 2014, 66 graduates of CORE have launched 13 companies and raised nearly $28M to commercialise their ideas. Graduates of CORE are eligible for post-program support with the following awards available (total value >$1000,000):

  • 2 x Scholar Program Awards to relocate to the Rosenmann Institute QB3 California Institute for Quantitative Biosciences, USA, for 2 years

  • Product Development Award 

  • International Discovery Grants 

  • Intellectual Property Strategy Award

  • Regulatory Strategy Award 

  • Cicada Innovations Incubation Award

Course Specifications

Through a series of workshops and events, CORE candidates will learn to “search” for the right business model for their technologies based on Lean LaunchPad methodologies and gain insights from over 30 mentors and domain experts on every facet of running a health related business: 

  • Intellectual Property

  • Regulatory and Reimbursement Strategies 

  • Financial Modelling and Pricing

  • Valuation

  • Capital Raising 

  • Business Governance 

  • Pitch Crafting

  • Negotiation and Influence. 

The course is modelled on experiential learning and a flipped classroom approach to engage candidates with real world entrepreneurship. This involves experimentation; getting out of the classroom and talking to customer, partners and competitors. 

Course Expectations

MDCTP CORE is structured in two parts; the “search” for the right business model and the ‘structural’ of aspects critical to medical device commercialisation. Candidates are expected to work in teams for the “search” component of the course, conducting customer interviews on the Team Lead’s technology, to develop skills to apply to their own technology. Candidates will work on their own technologies for the “structural” component of the course. 

MDCTP CORE requires a commitment of attending 1 full day per week for 12 weeks at Cicada Innovations in Sydney, up to 20 hours per week of customer interviews and homework and attending the graduation showcase in May 2018. 


Free! There is no cost for participants or their institutions as the Medical Device Commercialisation Training Program is funded by NSW Health, Office for Health and Medical Research.

Applications for CORE 2019 are open now

Sep 18 – Applications Open

23 Oct 18 – Applications Close

12 Nov 18 – Selection Interviews

04 Feb 19 – CORE Start

22 Apr 19 – CORE Finish

May 19 – Graduation and Showcase 



The MDCTP has proven its strategic value to the development of medical technology commercialisation capability within NSW over the past four years. In this short time graduates have launched new businesses, secured investment, developed and launched devices into the market, created skilled jobs and advanced their skills as professional innovators.



MDCTP Health is a half-day training course for 12 weeks for researchers, clinicians and graduates interested in creating maximum impact through their medical technology or research. The course guides candidates through customer discovery in the “search” for the correct business model to achieve social, health and economic impact in the global marketplace. MDCTP Health is based on Lean LaunchPad® methodology – based on the ‘search’ for the right business model using experimentation; getting out of the classroom and talking to customers, partners and competitors. The course goes beyond static case studies or fixed models and challenges candidates to create their own business models based on information derived from personal engagement rather than second hand market research.

Eligibility for MDCTP Health requires applicants to be NSW-based who are interested in creating impact through their medical technology or research. Applicants need to commit to the half-day course for 12 weeks plus up to 12 hours of homework each week. Applicants do not need their own intellectual property.

Course Expectations and Culture

Developed by Jerry Engel and Steve Blank, Lean LaunchPad® (LLP) has been taught at Stanford, Berkeley, Columbia, UCSF and was adopted by the National Science Foundation to increase the economic impact of research. It emphasises experiential learning, a flipped classroom and immediate feedback as a way to engage candidates with real world entrepreneurship. Lean LaunchPad® has a strong focus on the SEARCH for the correct business model. This involves experimentation; getting out of the classroom and talking to customers, partners and competitors.

Getting out of the lab/building is what the SEARCH effort is about. It’s not about the lectures. You will be spending a significant amount of time in between each of the lectures outside the lab/hospital talking to customers and testing your hypotheses. If candidates can’t commit the time to talk to customers, then this course is not for them.

Startups communicate very differently to communication inside a university, lab or hospital. It is dramatically different from the university or hospital culture most of the candidates are familiar with. Feedback at times will feel brusque and impersonal, but in reality, is focused and oriented to create immediate action in time and cash-constrained environments.


MDCTP Health 2018 is currently in session and ends Monday 5th November 2018.


MDCTP IP is a one-day workshop delivered together with Australia’s leading intellectual property firm, Davies Collison Cave, that focuses on intellectual property management strategies for medical devices. It is designed to equip candidates with the necessary knowledge to protect their intellectual property through trademarks, patents and design registration. Candidates will learn about the different types of intellectual property, protection strategies and how to speak about their medical research or technology without giving away their secret sauce.

MDCTP IP workshops are free to participants.

MDCTP IP courses run four times per year.  The next available IP workshop will be held at Cicada Innovations on 21st November 2018 from 9:00-17:00. 


Date and time TBC


Designed for medical entrepreneurs, researchers and clinical staff who want to understand more about the steps in developing a clinical trial from idea through to protocol, this 1-day workshop with Southern Star Research and Cicada Innovations will explore concepts such as:

  • Regulations Governing Clinical Trials in Australia

  • Setting up a Clinical Trial – insight into clinical trial protocols, site and CRO selection, ethical approval, budgeting and contracts

  • Device vigilance in the context of clinical trials

  • Biometrics departments and why you need them. Key roles and responsibilities

  • What you need to effectively resource a study and;

  • Hints and tips on where to find funding to get your trial off the ground.

At completion, participants will recognise the key milestones in progressing a clinical trial from idea through to clinical trial reporting.

The next available Clinical Trails Workshop will be held at Cicada Innovations on 22nd November 2018 from 9:00-17:00. 

Registrations are now closed for the Clinical Trials Workshop. Stay tuned for 2019 Workshops



The MDCTP course has been an incredibly valuable opportunity both for Sheridan and myself, giving us a sound basis from which to build our business, especially noting the importance of customer validation. The course has taught us not only what we should be doing now, but also what we should be preparing for. In the world of startups, timing can be critical and being aware and prepared helps to avoid falling into unwarranted regulatory, legal or other pitfalls down the track.

The commercialisation game is hard enough to play, and flying blind without a comprehensive understanding of the fundamentals is a recipe for failure. The MDCTP course gave us the momentum we needed to get out of the research facility and amongst the people we are trying to help and those that can help us make it happen.” 
Michael Weaver, Co-founder at Cenofex Innovations (Awarded the NSW-QB3 Rosenman Institute Program scholarship, MDCTP 2014).


The MDCTP was invaluable in teaching me how to commercialise a medical device and putting me in touch with key contacts within the field. I also learnt how to ‘pitch’. During the course my team worked on the ‘business model canvas’ for Kleer-i a sutureless surgery for the eye which helped with our successful application to the Medical Devices Fund.” 
Stephanie Watson, Eye Surgeon at Save Sight Institute, Founder at Kleer-i (Awarded with $50,000 Seed Funding, MDCTP 2015).


The MDCTP provided me with, not only the knowledge, but the experience of testing the validity of your idea in a market. We learnt the basics of many aspects necessary in commercialising a product and became familiar with the language used – this has already been of value in my role. But the key value of the course to me is that I now feel enabled to take an idea and systematically ask – does it solve a problem? for whom? and specifically what do I need to do to get it to them, and make a profit? I would certainly recommend it to people interested in commercialising their ideas, in fact I already do.” 
Stephen Bradford, Research Scientist in Genomics at CSIRO/Garvan Institute of Medical Research.



How is ‘medical device’ defined?
Any type of device, instrument, diagnostic, app, software or processing technology that aims to improve patient or health system outcomes. We do not accept pharmaceutical drugs.

What happens to my intellectual property during the course?
Non-disclosure agreements are signed by all parties involved in the course, and we do not require you to reveal any sensitive information. Background intellectual property remains with their original owners.



For further information please contact Ben Wright via Applications will only be accepted via the application form and will not be considered if they are sent via email.